Applications of proteomics to cell biology and biomedical research require further developments of mass spectrometry (MS) technology to overcome long-standing limitations in speed, sensitivity and ...

Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity Large-Scale Plasma Proteomics Typical Sequence Coverage >10 Peptides/protein and >100k ...

PORTLAND, Ore.--(BUSINESS WIRE)--At the 20 th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other ...

Emerging mass spectrometry technologies integrating ion mobility, TIMS–PASEF, and real-time search are enhancing sensitivity, throughput, and reproducibility in proteomics.

Bruker Corporation BRKR recently announced transformative sensitivity on the 4D-Proteomics timsTOF platform with the launch of the timsTOF Ultra mass spectrometer at the 71st ASMS meeting. The company ...

Comprehensive coverage of detected lipids with a corresponding MS/MS spectrum is required for confident lipidome characterization. With the timsTOF Pro and timsTOF fleX systems this is realized by the ...

Ion-mobility spectrometry (IMS) separates and characterizes ions in the gas phase based on their mobility within a carrier gas. IMS has recently being coupled with mass spectrometry (MS) and ...

We know very well that metabolites—small molecules such as lipids, sugars, nucleotides, and amino acids—play a large role in cellular biochemistry. But we are only beginning to understand the many ...